Beth Hecht - Net Worth and Insider Trading
Beth Hecht Net Worth
The estimated net worth of Beth Hecht is at least $180,097 dollars as of 2024-11-13. Beth Hecht is the See Remarks of Xeris Biopharma Holdings Inc and owns about 57,083 shares of Xeris Biopharma Holdings Inc (XERS) stock worth over $180,097. Details can be seen in Beth Hecht's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Beth Hecht has not made any transactions after 2020-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Beth Hecht
Beth Hecht Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Beth Hecht owns 4 companies in total, including Xeris Biopharma Holdings Inc (XERS) , Neos Therapeutics Inc (NEOS) , and Aytu BioPharma Inc (AYTU) among others .
Click here to see the complete history of Beth Hecht’s form 4 insider trades.
Insider Ownership Summary of Beth Hecht
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2021-10-05 | See Remarks |
| NEOS | Neos Therapeutics Inc | 2020-06-10 | director |
| AYTU | Aytu BioPharma Inc | 2021-03-19 | director |
 | | 2021-03-18 | director |
Beth Hecht Latest Holdings Summary
Beth Hecht currently owns a total of 1 stock. Beth Hecht owns 57,083 shares of Xeris Biopharma Holdings Inc (XERS) as of March 13, 2020, with a value of $180,097.
Latest Holdings of Beth Hecht
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings Inc | 2020-03-13 | 57,083 | 3.16 | 180,097 |
Holding Weightings of Beth Hecht
Beth Hecht Form 4 Trading Tracker
According to the SEC Form 4 filings, Beth Hecht has made a total of 2 transactions in Xeris Biopharma Holdings Inc (XERS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Xeris Biopharma Holdings Inc is the acquisition of 4,000 shares on March 13, 2020, which cost Beth Hecht around $7,880.
Insider Trading History of Beth Hecht
- 1
Beth Hecht Trading Performance
GuruFocus tracks the stock performance after each of Beth Hecht's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Beth Hecht is 36.91%. GuruFocus also compares Beth Hecht's trading performance to market benchmark return within the same time period. The performance of stocks bought by Beth Hecht within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Beth Hecht's insider trading performs compared to the benchmark.
Performance of Beth Hecht
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -19.39 | | | | | |
| Relative Return to S&P 500(%) | -14.04 | | | | | |
Beth Hecht Ownership Network
Ownership Network List of Beth Hecht
Ownership Network Relation of Beth Hecht
Beth Hecht Owned Company Details
What does Xeris Biopharma Holdings Inc do?
Who are the key executives at Xeris Biopharma Holdings Inc?
Beth Hecht is the See Remarks of Xeris Biopharma Holdings Inc. Other key executives at Xeris Biopharma Holdings Inc include Chief Financial Officer Steven Pieper , See Remarks Shannon John Patrick Jr , and director & See Remarks Paul R Edick .
Xeris Biopharma Holdings Inc (XERS) Insider Trades Summary
Over the past 18 months, Beth Hecht made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .
In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.
Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xeris Biopharma Holdings Inc Insider Transactions
Beth Hecht Mailing Address
Above is the net worth, insider trading, and ownership report for Beth Hecht. You might contact Beth Hecht via mailing address: C/o Neos Therapeutics, Inc., 2940 N. Highway 360, Grand Prairie Tx 75050.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
